CD8A and neoplasm: This checkpoint molecule expression may be transient, or below suppressive levels, since CD8+ TRM TIL in tumors exhibit superior anti-tumor activities and a positive prognosis has been correlated with the quality and quantity of these cells (248–250, 252–256).